Centogene Kohustused 2025

Mis teeb Centogene?

Centogene NV is a biotechnology company specializing in the research and diagnosis of rare genetic diseases. It was founded in 2006 by Arndt Rolfs and Christoph Lengauer in Rostock. The business model of Centogene NV is based on the application of genomic research and advanced technologies to develop novel diagnostic and therapeutic approaches. The company operates its own laboratories where DNA samples are analyzed and evaluated. The goal is to identify the genetic causes of rare diseases and provide patients with personalized treatment options. The company operates in several areas. One focus is on the diagnosis of rare diseases that have unclear genetic causes. The company offers a wide range of genetic tests that aim to enable fast and precise diagnosis. These include exome sequencing, RNA analysis, and gene panel tests. Another business field of Centogene NV is the development of new therapy approaches for rare diseases. The company collaborates with pharmaceutical companies and clinical researchers to develop innovative drugs and conduct clinical trials. The aim is to offer improved treatment options and enhance the quality of life for patients with rare diseases. Centogene NV is headquartered in Rostock, Germany, but also has offices in Lisbon, Portugal, Dubai, United Arab Emirates, and Boston, USA. The company operates globally and collaborates with medical centers and research laboratories worldwide. A special feature of Centogene NV is the CentoMD® database system. This is an extensive genetic database that contains clinical and genetic information from patients with rare diseases. This database is a valuable resource for diagnosis, research, and the development of new therapy approaches. The company works closely with patient groups and international organizations to raise awareness of rare diseases and create better treatment options. Centogene NV is also involved in the education and training of medical professionals to ensure better care for patients. Overall, Centogene NV is a leading company in the research and diagnosis of rare genetic diseases. The business model is based on the application of cutting-edge genomic research and technologies to provide patients with personalized treatment options. The company operates globally and has its own laboratories and extensive genetic database. Centogene NV is actively involved in research and education to improve the care of patients with rare diseases. Centogene ist eines der beliebtesten Unternehmen auf Eulerpool.com.